排卵検査薬市場：製品別、流通チャネル別、地域別、2026～2032年

排卵検査薬市場の評価、2026～2032年

女性の間で生殖に関する健康と生殖能力に関する知識が高まるにつれ、正確な排卵予測技術に対する需要が高まっています。さらに、出生率の上昇と出産を先延ばしにする傾向の高まりが、効率的な家族計画の選択肢を求める人を増やしています。技術の進歩も後押ししており、デジタル検査やアプリ一体型検査のような技術革新が精度と使い心地を向上させ、2024年には47億1,000万米ドル、2032年には63億7,000万米ドルに達する勢いです。

さらに、eコマースプラットフォームの台頭により、これらの検査がより身近なものとなり、市場成長が加速しています。また、企業のマーケティング活動や教育プログラムの強化も認知度を高め、消費者の関心を喚起しており、2026～2032年までのCAGRは約3.85%で成長すると予想されます。

排卵検査薬市場の定義/概要

排卵検査薬は、排卵前に発生する黄体形成ホルモン（LH）の増加を検出することにより、女性の月経周期の中で最も妊娠しやすい日を決定するために使用される診断機器です。主な用途は、妊娠の補助、生殖に関する健康のモニタリング、妊娠の計画や予防などです。排卵検査の将来は楽観的であり、リアルタイム追跡やデータ分析のためのスマートフォンアプリとの統合など、精度と使いやすさを向上させる技術開発が期待されています。不妊治療に関する知識が深まるにつれて、これらの検査はより複雑化し、より多くのバイオマーカーを統合し、個別化された生殖健康管理を可能にする幅広い機能を提供するようになると予測されます。

女性の生殖健康と不妊に対する意識の高まりは排卵検査薬市場を促進するか？

生殖に関する健康と不妊に対する意識が高まっています。より多くの女性が率先して家族計画を立て、生殖の健康を管理するようになったため、排卵検査薬に対する需要が増加しています。自分の月経周期を知り、生殖能力を最大化することの重要性に対する一般大衆の認識を高めるには、教育、メディア注目、健康関連活動のキャンペーンが不可欠です。Verified Market Researchが2023年7月に発表した徹底的な市場分析によると、世界の排卵検査薬市場は、2023年には1,000億米ドル規模になると予測されています。世界の排卵検査薬市場は、2023～2031年にかけてCAGR3.85％で拡大し、2032年までに63億7,000万米ドルに達すると予測されており、同レポートは、家庭用排卵検査キットの需要増加は、不妊治療と生殖医療に関する教育と啓発活動の増加の結果であると指摘しています。

米国産科婦人科学会（ACOG）は、そのガイドラインの中で不妊に関する認識の役割をより重視しています。これは消費者の知識を増やし、排卵モニタリング機器の需要に貢献しています。企業は製品ラインを改善することで対応しています。例えば、2023年8月、Clearblueはアドバンストデジタル排卵検査薬の発売を発表しました。

例えば、2024年7月、米国保健社会福祉省（HHS）は、最先端の診断機器を含む不妊に関するリソースや情報への女性のアクセスを向上させることを目的とした新しい取り組みを発表しました。国民の意識を高めるだけでなく、政府は不妊治療関連製品への投資と技術革新を促進しています。

検査精度のばらつき増加は排卵検査薬市場の成長を妨げるか？

検査精度のばらつきの増加は、消費者の信頼と製品の信頼性に直接影響するため、排卵検査薬ビジネスにとって深刻な懸念事項です。排卵検査薬はホルモンの急増を利用して最も妊娠しやすい日を予測しますが、ホルモンレベルの個人差、不規則な月経周期、検査スケジュールなどはすべて矛盾した結果を引き起こす可能性があります。このような変動は、偽陰性や偽陽性につながる可能性があり、悪化の原因となり、製品に対するユーザーの信頼を損なう可能性があります。このような矛盾は、消費者がこれらの検査に頼ることを思いとどまらせ、別の手法や解決策を求めるよう促し、市場の成長を阻害する可能性があります。

こうした障害に対処し発展を維持するために、メーカーは検査の精度とユーザー教育を優先しなければなりません。より高感度な検査やデジタル統合などの技術進歩は、精度を向上させ、ばらつきを減らすことができます。さらに、検査の利用方法やデータの解釈方法についてきちんと説明することで、消費者が教育的な判断を下し、全体的な満足度を高めることができます。検査精度に関連する固有の障害にかかわらず、消費者の信頼を維持し、継続的な市場成長を生み出すためには、組織はこれらの問題に積極的に対処しなければなりません。

目次

第1章 イントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 市場概要

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 排卵検査薬市場：製品別

• 概要
• 尿検査薬
• 排卵検査薬
• デジタル排卵検査薬

第6章 排卵検査薬市場：流通チャネル別

• 概要
• 薬局・ドラッグストア
• eコマース

第7章 排卵検査薬市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第9章 企業プロファイル

• Swiss Precision Diagnostics
• Church & Dwight
• Prestige Consumer Healthcare
• HiLin Life Products
• Fairhaven Health
• Geratherm Medical
• Piramal Enterprises
• NecLife
• Fertility Focus Limited
• Accuquik

第10章 主な発展

• 製品上市／開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第11章 付録

• 関連調査

Ovulation Test Market Valuation - 2026-2032

The growing knowledge of reproductive health and fertility among women has increased demand for precise ovulation prediction technologies. Furthermore, rising fertility rates and a growing tendency of postponing childbearing are encouraging more people to seek efficient family planning alternatives. Advances in technology have also helped, with innovations like digital and app-integrated exams improving accuracy and user comfort is fuelling the USD 4.71 Billion in 2024 and reaching USD 6.37 Billion by 2032.

Furthermore, the rise of e-commerce platforms has made these tests more accessible, hence accelerating market growth. Companies' enhanced marketing efforts and educational programs are also raising awareness and driving consumer interest, which is fueling market expected to grow at a CAGR of about 3.85% from 2026 to 2032.

Ovulation Test Market: Definition/ Overview

An ovulation test is a diagnostic instrument used to determine the most fertile days of a woman's menstrual cycle by detecting the increase in luteinizing hormone (LH) that occurs before ovulation. Its main applications include assisting with conception, monitoring reproductive health, and planning or preventing pregnancy. The future of ovulation testing seems optimistic, with technological developments anticipated to improve accuracy and usability, such as integration with smartphone apps for real-time tracking and data analysis. As knowledge of fertility health grows, these tests are projected to become more complex, integrating more biomarkers and providing broader functions to enable personalised reproductive health management.

Will Increasing Awareness of Reproductive Health and Fertility among Women Propel the Ovulation Test Market?

The growing awareness of reproductive health and fertility. The demand for ovulation tests has increased as more women take the initiative to plan their families and manage their reproductive health. Campaigns for education, media attention, and health-related activities have been essential in increasing public awareness of the significance of knowing one's menstrual cycle and maximizing fertility. According to a thorough market analysis released by Verified Market Research in July 2023. The global ovulation test market is anticipated to reach $ 6.37 billion by 2032, expanding at a compound annual growth rate (CAGR) of 3.85% between 2023 and 20301, the report notes that a rise in demand for at-home ovulation testing kits is a result of increased education and awareness initiatives around fertility and reproductive health.

The American College of Obstetricians and Gynecologists (ACOG) has placed a higher emphasis on the role of fertility awareness in its guidelines. This has increased consumer knowledge and contributed to the demand for ovulation monitoring equipment. Businesses are responding by improving their product lines. For instance, in August 2023, Clearblue has announced the release of their Advanced Digital Ovulation Test, incorporating more advanced technology to satisfy growing customer demand.

For instance, in July 2024, the U.S. Department of Health and Human Services (HHS) unveiled a new effort designed to increase women's access to resources and information about fertility, including cutting-edge diagnostic equipment. In addition to raising public awareness, this government focus promotes investment and innovation in fertility-related products.

Will Rising Variability in Test Accuracy Hinder the Growth of the Ovulation Test Market?

Rising variability in test accuracy is a serious concern for the ovulation test business since it directly affects consumer trust and product reliability. Ovulation tests use hormonal surges to forecast the most fertile days, but individual variances in hormone levels, irregular menstrual cycles, and test scheduling can all cause conflicting results. Such fluctuation might lead to false negatives or positives, causing aggravation and potentially damaging users' trust in the product. This inconsistency may dissuade consumers from depending on these tests, prompting them to seek alternate techniques or solutions, so impeding market growth.

To address these obstacles and maintain development, manufacturers must prioritize test accuracy and user education. Technological advancements, such as more sensitive tests or digital integration, can improve precision and reduce variability. Furthermore, good instructions on how to utilize the tests and interpret the data can help consumers make educated decisions, increasing overall satisfaction. Regardless of the inherent obstacles connected with test accuracy, organizations must address these issues proactively in order to preserve consumer trust and generate continued market growth.

Category-Wise Acumens

Will Increasing Demand of Urine Ovulation Test Propel the Ovulation Test Market?

The growing demand for urine ovulation tests is projected to drive the ovulation test industry. Urine ovulation tests are popular because to their low cost, ease of use, and accuracy in detecting the luteinizing hormone (LH) spike, which aids in determining the fertile window. These advantages make them a popular choice among many consumers, particularly in developing countries where cost-effective solutions are critical. In August 2023, Clearblue announced a new series of urine-based ovulation kits, with better sensitivity and simplicity of interpreting findings, which is predicted to boost market demand even higher. Furthermore, these tests are readily available in both physical and online retail channels, expanding their exposure to customers.

In July 2023, the World Health Organization (WHO) initiated a campaign to enhance access to reproductive health goods in low-income nations, emphasizing the importance of affordable fertility treatments such as urine ovulation testing. Similarly, in September 2023, the United States Food and Drug Administration (FDA) authorized new over-the-counter urine ovulation tests, shortening the regulatory process and allowing for faster market access. These regulatory measures and government support for reproductive health are increasing demand for urine ovulation tests, which is boosting overall market growth.

The digital ovulation test segment is the fastest growing. These tests provide improved accuracy, user-friendly digital displays, and advanced capabilities such as Bluetooth connectivity and smartphone integration, making them appealing to tech-savvy consumers seeking more precise fertility tracking. Demand for digital ovulation tests has increased, particularly in developed economies where customers are prepared to invest in modern healthcare technologies to improve fertility management. This trend is projected to continue as more consumers seek out smart health solutions.

Will Rising Sales through E-Commerce Fuel the Ovulation Test Market?

Rising e-commerce sales are driving growth in the ovulation test market. The convenience and accessibility provided by internet platforms have made ovulation test kits more widely available to customers, adding to rising demand. The COVID-19 pandemic has expedited the trend to online purchasing, with many customers turning to e-commerce platforms to buy personal health products such as fertility and ovulation test kits. In July 2023, Fairhaven Health, a fertility product manufacturer, stated that it expanded its e-commerce channels to capitalize on increased consumer demand for at-home reproduction treatments.

In March 2023, the United States Department of Health and Human Services (HHS) announced measures to improve telehealth and remote healthcare services, hence increasing online sales of home healthcare items. In September 2023, the Indian government implemented laws to reduce regulatory processes for e-commerce enterprises, with the goal of stimulating the digital economy and providing customers across the country with access to a broader selection of health and wellness items, including ovulation testing. These government efforts to boost the digital economy are resulting in higher online sales, which are driving the expansion of the ovulation test market.

Pharmacies and drugstores continue to be the fastest expanding distribution channel, because to their established presence, consumer trust, and capacity to provide professional advise in person. Many clients continue to prefer to buy health products from physical stores, where they can get fast advice and check product legitimacy.

Country/Region-wise

Will High Availability of Fertility Products in North America Drive the Ovulation Test Market?

The widespread availability of fertility products in North America is a major driver of the ovulation test business.CVS Health, one of the major pharmacy chains in the United States, announced in September 2023 that it would expand its fertility wellness division to over 1,500 stores nationally. This expansion featured a greater selection of ovulation test kits and related items, increasing their visibility and accessibility to consumers. Furthermore, in October 2023, Amazon reported a 35% year-over-year growth in ovulation test kit sales on its platform, indicating an increasing consumer preference for online shopping of these products. The e-commerce giant has also added a new "Fertility and Ovulation" category to its website, making it easier for users to identify and compare different brands and types of ovulation test.

In July 2023, the United States Food and Drug Administration (FDA) authorized several new over-the-counter ovulation test kits, expanding the range of goods available to customers. This regulatory assistance has encouraged additional companies to enter the industry, resulting in greater competition and innovation. For instance, in November 2023, Procter & Gamble's Clearblue brand introduced a new line of ovulation test strips tailored exclusively for the North American market, with increased sensitivity and easier-to-read findings. The company highlighted the region's high demand and openness to novel reproductive solutions as important considerations in their choice to launch this line.

Will Rising Adoption of at-Home Health Diagnostic in Asia Pacific Propel the Ovulation Test Market?

The growing popularity of at-home health diagnostics is driving the ovulation test industry. Consumers are increasingly turning to at-home diagnostic technologies for convenience, privacy, and cost-effectiveness, particularly in the areas of fertility and reproductive health. This tendency has led to an increase in demand for ovulation tests, which are an important aspect of fertility tracking. In August 2023, Mira, a Femtech firm, announced the introduction of its AI-powered ovulation tracking device. It combines at-home urine testing with a smartphone app to provide individualized fertility insights. The company claimed a 150% year-over-year revenue gain, demonstrating substantial consumer interest in advanced, user-friendly at-home fertility testing.

In June 2023, Prega News introduced a new range of low-cost ovulation test kits in India, catering to the growing number of women seeking at-home fertility monitoring solutions. E-commerce platforms such as Alibaba, Amazon, and Flipkart have made these products more accessible, accelerating market growth. Similarly, in September 2023, the Chinese National Health Commission announced intentions to raise public awareness about fertility and reproductive health, including promoting the use of home-based diagnostic equipment as part of the national family planning strategy. These government efforts, together with the increasing availability of at-home health diagnostic equipment, are projected to drive the growth of the ovulation test market in Asia Pacific.

Competitive Landscape

The ovulation test market is highly competitive, featuring a range of players from large multinational corporations to smaller niche companies. The industry is characterized by continuous innovation in test accuracy, ease of use, and affordability. Companies are increasingly focusing on integrating digital technology, such as smartphone apps and Bluetooth connectivity, to enhance user experience and accuracy. Additionally, there is a growing emphasis on natural and hormone-free testing methods to cater to health-conscious consumers. The market's competitive dynamics are influenced by rapid technological advancements, evolving consumer preferences, and the increasing awareness of fertility health, all of which drive companies to differentiate their products and services.

Some of the prominent players operating in the ovulation test market include:

Swiss Precision Diagnostics GmbH

Prestige Consumer Healthcare Inc.

Fairhaven Health LLC

Geratherm Medical AG

Piramal Enterprises Ltd

NecLife

Easy@Home Fertility

Wondfo

Accuquik

PREGMATE

Runbio Biotech Co. Ltd.

Hilin Life Products

Church & Dwight Co., Inc.

Latest Developments

In May 2023, iProven announced a new dual-pack solution that includes digital and urine ovulation tests, providing users with numerous fertility tracking options. The solution is aimed at users who want more precision and flexibility in their fertility monitoring regimens.

In June 2023, Modern Fertility introduced ovulation test strips as part of its increasing fertility product line. The test strips are part of the company's larger objective to make fertility care more accessible and inexpensive for women throughout the United States.

In September 2023, The Bayer AG announced ambitions to enter the Asia-Pacific ovulation test market, using its strong presence in women's health goods. The company's initial concentration will be in China and India, where demand for reproductive products is quickly increasing.

Ovulation Test Market, By Category

• Product
• Urine
• Ovulation Test
• Digital Ovulation Test
• Distribution Channel
• Pharmacies and Drugstores
• E-Commerce
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL OVULATION TEST MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL OVULATION TEST MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL OVULATION TEST MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Urine
• 5.3 Ovulation Test
• 5.4 Digital Ovulation Test

6 GLOBAL OVULATION TEST MARKET, BY DISTRIBUTION CHANNEL

• 6.1 Overview
• 6.2 Pharmacies and Drugstores
• 6.3 E-Commerce

7 GLOBAL OVULATION TEST MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL OVULATION TEST MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Swiss Precision Diagnostics
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Church & Dwight
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Prestige Consumer Healthcare
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 HiLin Life Products
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Fairhaven Health
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Geratherm Medical
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Piramal Enterprises
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 NecLife
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Fertility Focus Limited
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Accuquik
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research